Package Leaflet: Information for the Patient
Fampridina Teva 10 mg prolonged-release tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Fampridina Teva is a medicine used to improve walking in adults (18 years or older) with walking disability related to multiple sclerosis (MS). In multiple sclerosis, inflammation destroys the protective covering of the nerves, causing muscle weakness, muscle stiffness, and difficulty walking.
This medicine contains the active substance fampridine, which belongs to a group of medicines called potassium channel blockers. They work by preventing potassium from leaving damaged nerve cells in multiple sclerosis. It is thought that this medicine works by allowing signals to pass through the nerve more normally, which helps you walk better.
DO NOT takeFampridina Teva
Tell your doctor and DO NOT takethis medicine if any of the above applies to you.
Warnings and precautions
Talk to your doctor or pharmacist before taking this medicine:
Tell your doctor before takingthis medicine if any of the above applies to you.
Children and adolescents
Do not give this medicine to children or adolescents under 18 years.
Elderly patients
Before starting treatment and during treatment, your doctor may check that your kidneys are working properly.
Other medicines and Fampridina Teva
Tell your doctor or pharmacistif you are taking, have recently taken or might take any other medicines.
DO NOT takethis medicineif you are taking any other medicine that contains fampridine.
Other medicines that affect the kidneys
Your doctor will be careful if you receive fampridine at the same time as another medicine that may affect the elimination of other medicines by the kidneys, such as carvedilol, propranolol, and metformin.
Pregnancy and breast-feeding
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacistfor advice before taking this medicine.
This medicine is not recommended during pregnancy.
Your doctor will weigh the benefit of treatment with this medicine for you against the risk for the baby.
Do not breast-feedwhile you are taking this medicine.
Driving and using machines
This medicine may affect your ability to drive or use machines, it can cause dizziness. Make sure it does not affect you before you start driving or using machines.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. This medicine is only available with a doctor's prescription and under the supervision of a doctor with experience in the treatment of multiple sclerosis.
Your doctor will initially prescribe treatment for 2 to 4 weeks. After 2 to 4 weeks, the treatment will be reassessed.
The recommended dose is
Onetablet in the morning and onetablet in the evening (with a 12-hour interval). Do not take more than two tablets a day. You must wait 12 hoursbetween each tablet. Do not take the tablets more often than every 12 hours.
This medicine is for oral use.
Swallow each tablet whole, with a glass of water. Do not divide, crush, dissolve, suck, or chew the tablet. This may increase the risk of side effects.
This medicine should be taken without food, on an empty stomach.
If you take more Fampridina Teva than you should
Contact your doctor immediatelyif you have taken too many tablets.
If you go to a doctor, take the pack of this medicine with you.
In an overdose, you may notice sweating, small shakes (tremors), dizziness, confusion, memory loss (amnesia), and seizures (fits). You may also notice other side effects not mentioned here.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Fampridina Teva
If you forget to take a tablet, do not take a double dose to make up for forgotten doses. There must always be 12 hoursbetween each tablet.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you have a seizure, stop takingthis medicineand tell your doctor immediately.
If you experience one or more of the following allergic reactions (hypersensitivity): swelling of the face, mouth, lips, throat, or tongue, redness or itching of the skin, chest tightness, and breathing problems, stop takingthis medicineand go to your doctor immediately.
The following side effects are listed by frequency:
Very common side effects(may affect up to 1 in 10 people)
Common side effects(may affect up to 1 in 10 people)
Uncommon side effects(may affect up to 1 in 100 people)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and the carton after EXP. The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Store in the original package to protect from light and moisture.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What Fampridina Teva contains
Appearance and packaging
The tablets are white to off-white, biconvex, oval-shaped, film-coated, with the inscription R10 on one side and no inscription on the other. The dimensions of the tablets are approximately 8 mm x 13 mm.
Fampridina Teva is available in blister packs of 28 and 56 tablets and unit-dose blister packs of 28x1 and 56x1 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Teva Pharma, S.L.U.
C/ Anabel Segura, 11, Edificio Albatros B, 1ª planta,
Alcobendas 28108
Madrid (Spain)
Manufacturer
Balkanpharma Dupnitsa AD
3, Samokovsko Shosse Str.
Dupnitsa 2600
Bulgaria
This medicine is authorised in the Member States of the European Economic Area under the following names:
Germany: Fampridin-ratiopharm 10 mg Retardtabletten
Croatia: Fampridin Teva 10 mg tablete s produljenim oslobadanjem
Denmark: Fampridin Teva
Spain: Fampridina Teva 10 mg comprimidos de liberación prolongada EFG
Slovakia: Fampridín Teva 10 mg tablety s predlženým uvolnovaním
Slovenia: Fampridin Teva 10 mg tablete s podaljšanim sprošcanjem
France: FAMPRIDINE TEVA LP 10 mg, comprimé à libération prolongée
Lithuania: Fampridine Teva 10 mg pailginto atpalaidavimo tabletes
Netherlands: Fampridine Teva 10 mg, tabletten met verlengde afgifte
Norway: Fampridin Teva
Poland: Fampridine Teva
Portugal: Fampridina Teva
Czech Republic: Fampridine Teva
Date of last revision of this leaflet:July 2021
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es